A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Assistance Publique – Hôpitaux de Paris · Centre Hospitalier Universitaire de Bordeaux · +12 more institutions
Abstract
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages. In the general population, its incidence is approximately 1/40,000 to 1/60,000 births, rising to 1/800 in Ashkenazi Jews. The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells. Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera,…
Citation impact
- FWCI
- 33.37
- Percentile
- 100%
- References
- 211
Authors
13Topics & keywords
- Enzyme replacement therapy
- Glucocerebrosidase
- Medicine
- Substrate reduction therapy
- Disease
- Cytopenia
- Gaucher's disease
- Lysosomal storage disease
- Good health and well-being